Héloïse M. Leclair
Impact in
-
- NF-κB Signaling Pathways
-
- interferon and immune responses
- Immune Cell Function and Interaction
Papers in
-
- Melanoma and MAPK Pathways 4
- Ubiquitin and proteasome pathways 1
- Epigenetics and DNA Methylation 1
- Oncology 5
- Chemokine receptors and signaling 1
- Peptidase Inhibition and Analysis 1
- Co-authors
- Julie Gavard (8 shared papers)Nicolas Bidère (7 shared papers)Sonia M. Dubois (3 shared papers)Catherine Alexia (4 shared papers)Karin Tarte (2 shared papers)Sandy Azzi (4 shared papers)Marie‐Dominique Galibert (4 shared papers)Sébastien Corre (4 shared papers)
- Journals
- Cell Communication and Signaling (3 papers)EMBO Molecular Medicine (2 papers)Nature Communications (1 paper)Brain (1 paper)BMC Cell Biology (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Héloïse M. Leclair
12 papers receiving 401 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 85
- Immunology 121
- Biological Psychiatry 13
- Pharmacology 56
- Oncology 86
Countries citing papers authored by Héloïse M. Leclair
This map shows the geographic impact of Héloïse M. Leclair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Héloïse M. Leclair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Héloïse M. Leclair more than expected).
Fields of papers citing papers by Héloïse M. Leclair
This network shows the impact of papers produced by Héloïse M. Leclair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Héloïse M. Leclair. The network helps show where Héloïse M. Leclair may publish in the future.
Co-authors
The 25 scholars most cited alongside Héloïse M. Leclair, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 83 | |
| 2 | 2014 | 82 | |
| 3 | 2017 | 71 | |
| 4 | 2013 | 33 | |
| 5 | 2013 | 27 | |
| 6 | 2021 | 21 | |
| 7 | 2022 | 20 | |
| 8 | 2015 | 17 | |
| 9 | 2014 | 15 | |
| 10 | 2013 | 13 | |
| 11 | 2020 | 11 | |
| 12 | 2015 | 9 |
About Héloïse M. Leclair
Héloïse M. Leclair is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Genetics, having authored 12 papers that have together received 402 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), Ubiquitin and proteasome pathways (1 paper), NF-κB Signaling Pathways (1 paper), Epigenetics and DNA Methylation (1 paper), Immunotherapy and Immune Responses (1 paper), Chemokine receptors and signaling (1 paper), Peptidase Inhibition and Analysis (1 paper) and Optimism, Hope, and Well-being (1 paper). The work is most often cited by research in Cancer Research (85 citations), Immunology (121 citations), Biological Psychiatry (13 citations), Pharmacology (56 citations) and Oncology (86 citations). Héloïse M. Leclair has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Julie Gavard, Nicolas Bidère, Sonia M. Dubois, Catherine Alexia, Karin Tarte, Sandy Azzi, Marie‐Dominique Galibert, Sébastien Corre, Lucas Treps and Zhijian J. Chen. Their work appears in journals such as Cell Communication and Signaling, EMBO Molecular Medicine, Nature Communications, Brain and BMC Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.